MEN1 has been reported to act as an oncogenic factor in various solid tumors, such as hepatocellular carcinoma (Kempinska et al., 2018), breast cancer (Dreijerink et al., 2017), and PCa (Kim et al., 2022). Here, MEN1 is linked to breast cancer.